🚨 84.4% OF CANCER PATIENTS REPORTED BENEFIT AFTER IVERMECTIN + MEBENDAZOLE: HERE'S WHAT THE STUDY FOUND Nicolas Hulscher is discussing what he describes as the largest human study to date examining ivermectin and mebendazole in cancer patients. And the numbers are getting